Epstein-Barr virus: exploiting the immune system (Q34572150)

3 August 2017

1 reference

title

Epstein-Barr virus: exploiting the immune system (English)

1 reference

3 August 2017

0 references

0 references

Thorley-Lawson DA

1

1 reference

3 August 2017

1 October 2001

1 reference

Nature Reviews Immunology

3 August 2017

1 reference

3 August 2017

1

1 reference

3 August 2017

75-82

1 reference

3 August 2017

1

1 reference

Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients

3 August 2017

1 reference

7 January 2021

EBV persistence involves strict selection of latently infected B cells

1 reference

7 January 2021

EBV persistence in memory B cells in vivo.

1 reference

7 January 2021

Is EBV persistence in vivo a model for B cell homeostasis?

1 reference

7 January 2021

A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals

1 reference

7 January 2021

Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene

1 reference

7 January 2021

The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM

1 reference

7 January 2021

X-linked lymphoproliferative syndrome registry report

1 reference

7 January 2021

X-linked recessive progressive combined variable immunodeficiency (Duncan's disease)

1 reference

7 January 2021

Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus

1 reference

7 January 2021

Epstein-Barr virus susceptibility of normal human B lymphocyte populations

1 reference

7 January 2021

Early events in Epstein-Barr virus infection provide a model for B cell activation

1 reference

7 January 2021

Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts

1 reference

7 January 2021

The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell

1 reference

7 January 2021

Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors

1 reference

7 January 2021

A model for persistent infection with Epstein-Barr virus: the stealth virus of human B cells

1 reference

7 January 2021

Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.

1 reference

7 January 2021

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

1 reference

7 January 2021

Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals

1 reference

7 January 2021

Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

1 reference

7 January 2021

1 reference

7 January 2021

Mechanism of antigen-driven selection in germinal centres

1 reference

7 January 2021

Germinal center development

1 reference

7 January 2021

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

1 reference

7 January 2021

Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling

1 reference

7 January 2021

The CD40 antigen and its ligand

1 reference

7 January 2021

Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor

1 reference

7 January 2021

Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival.

1 reference

7 January 2021

Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases

1 reference

7 January 2021

Genetic analysis of B cell antigen receptor signaling

1 reference

7 January 2021

Memory B-cell persistence is independent of persisting immunizing antigen.

1 reference

7 January 2021

In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death.

1 reference

7 January 2021

The transmission of infectious mononucleosis

1 reference

7 January 2021

Notch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus

1 reference

7 January 2021

Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils

1 reference

7 January 2021

A chemokine-driven positive feedback loop organizes lymphoid follicles

1 reference

7 January 2021

c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.

1 reference

7 January 2021

Activated Notch1 can transiently substitute for EBNA2 in the maintenance of proliferation of LMP1-expressing immortalized B cells

1 reference

7 January 2021

Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses

1 reference

7 January 2021

Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma

1 reference

7 January 2021

EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency

1 reference

7 January 2021

Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations

1 reference

7 January 2021

Vaccine strategies against Epstein-Barr virus-associated diseases: lessons from studies on cytotoxic T-cell-mediated immune regulation

1 reference

7 January 2021

Human immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression

1 reference

7 January 2021

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

1 reference

7 January 2021

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

1 reference

7 January 2021

The molecular and cellular origins of Hodgkin's disease

1 reference

7 January 2021

Expression of epstein-barr virus encoded nuclear antigen 1 in benign and malignant tissues harbouring EBV.

1 reference

7 January 2021

Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease

1 reference

7 January 2021

Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells

1 reference

7 January 2021

Regional specialization in the mucosal immune system: primed cells do not always home along the same track

1 reference

7 January 2021

Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells

1 reference

7 January 2021

1 reference

7 January 2021

Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo

1 reference

7 January 2021

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

1 reference

7 January 2021

Marker band in one chromosome 14 from Burkitt lymphomas.

1 reference

7 January 2021

Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line

1 reference

7 January 2021

Cancer of the head and neck. Nasopharyngeal cancer. Epidemiology and etiology

1 reference

7 January 2021

Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: Correlated nucleic acid hybridization and histopathological examination

1 reference

7 January 2021

Diet and nasopharyngeal carcinoma: a case-control study in Guangzhou, China

1 reference

7 January 2021

The Epstein-Barr virus: a group 1 carcinogen?

1 reference

7 January 2021

Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells

1 reference

7 January 2021

Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

1 reference

7 January 2021

Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade

1 reference

7 January 2021

Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region

1 reference

7 January 2021

Localization of the major NF-kappaB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs

1 reference

7 January 2021

The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB

1 reference

7 January 2021

LMP1 signal transduction differs substantially from TNF receptor 1 signaling in the molecular functions of TRADD and TRAF2

1 reference

7 January 2021

Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway

1 reference

7 January 2021

Identifiers

DOI

10.1038/35095584

1 reference

3 August 2017

1 reference

PubMed ID

11905817